Tech Company Financing Transactions

Zenas BioPharma Funding Round

On 5/9/2024, Zenas BioPharma announced $200 million in Series C funding from Delos Capital, New Enterprise Associates and Norwest Venture Partners.

Transaction Overview

Company Name
Announced On
5/9/2024
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series C
Proceeds Purpose
The company intends to use the funds to advance ongoing mid- to late-stage clinical development programs for its lead product candidate, obexelimab, a bifunctional monoclonal antibody designed to bind both CD19 and Fc?RIIb to inhibit the activity of B cells, plasmablasts, and CD19-expressing plasma cells.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Winter St North Building 1200
Waltham, MA 02451
USA
Phone
Undisclosed
Email Address
Overview
Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology based therapies for patients in need. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases.
Profile
Zenas BioPharma LinkedIn Company Profile
Social Media
Zenas BioPharma Company Twitter Account
Company News
Zenas BioPharma News
Facebook
Zenas BioPharma on Facebook
YouTube
Zenas BioPharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hua Mu
  Hua Mu LinkedIn Profile  Hua Mu Twitter Account  Hua Mu News  Hua Mu on Facebook
Chief Operating Officer
Joe Farmer
  Joe Farmer LinkedIn Profile  Joe Farmer Twitter Account  Joe Farmer News  Joe Farmer on Facebook
Founder
Lonnie Moulder
  Lonnie Moulder LinkedIn Profile  Lonnie Moulder Twitter Account  Lonnie Moulder News  Lonnie Moulder on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/9/2024: FleetPulse venture capital transaction
Next: 5/9/2024: SorbiForce venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary